UCB, a global biopharmaceutical company, announced the detailed results of the head-to-head phase 3 BE SURE study, which demonstrated that patients treated with investigational IL-17A and IL-17F ...
Can an over-the-counter product help you avoid the dreaded effects of a night out on the town, or is it just another supplement making big promises? That’s the question facing Sure Shot, a product ...
Forbes contributors publish independent expert analyses and insights. I cover cannabis capitalism: legalization’s winners, losers, scammers and suckers. How do you tell if someone is high or not—but, ...
- Data from the Phase 3 BE SURE study demonstrated that patients treated with investigational IL-17A and IL-17F inhibitor bimekizumab achieved significantly higher PASI 90 and PASI 100 skin clearance ...
Let's talk about pollution and five countries in Asia. Or, more specifically, let's talk about the study that people like to cite from 2015 claiming that five countries in Asia — China, Indonesia, the ...
Gabriella Conti receives funding from the Nuffield Foundation (grant number EYP 42289). She is a Research Fellow of the Institute for Fiscal Studies and a Trustee of Foundation Years Information and ...
Are you interested in starting a study group but not sure where to start? Or do you have a study group and want to enhance its effectiveness? Look here for advice on starting and maintaining a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results